Preservation and Expansion of T-cell Subsets Following HAART De-intensification to Atazanavir/Ritonavir (ATV/r)
Clinical trial NCT00491556 · COMPLETED
Trial details
- NCT number
- NCT00491556
- Sponsor
- University of North Carolina, Chapel Hill
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2007-10-01
- Primary completion
- 2013-06-01
- Enrollment
- 102
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.